p53-LNP only slightly prolonged survival, but CPX-LNP and CPX/p53-LNP increased survival by over a week, suggesting that CPX can enhance anti-tumor effect and prolong survival in mice burdened with tumors that respond poorly to p53 therapy (Figure 5M). This evidence concerns the gene TP53 and neoplasm.